[Feasibility and results of transcatheter treatment of patent foramen ovale associated with atrial septal aneurysm. Experience of a general hospital in Mulhouse, France]

Ann Cardiol Angeiol (Paris). 2007 Nov;56(5):201-7. doi: 10.1016/j.ancard.2007.08.004. Epub 2007 Sep 6.
[Article in French]

Abstract

Objective: To evaluate the results and the feasibility of the technique of percutaneous closing of patent foramen oval (PFO) with Atrial Septal Aneurysm (ASA) among young patients having presented a cryptogenic cerebral ischemia.

Patients and methods: Eighteen patients: 14 cryptogenic stroke and 4 TIA with a broad PFO (rank III) and an important ASA (excursion higher than 15 mm) at transesophageal echocardiography (TEE). The average age is 48.2 years: man 61%, women 39%. The patients have little cardiovascular risk factor (0.83/patient) and 38% presented recurrent thromboembolic events. Percutaneous closing is carried out under general anaesthesia with TEE and Amplatzer devices implantation. A control TEE is carried out 6 months after closing.

Results: No complication occurred at the time of the procedures. After 72 hours, one patient presented a major complication: one arteriovenous fistula requiring a surgery. Five patients presented a minor complication: two non complicated femoral hematoma, two atrial arrhytmias and one asymptomatic secondary displacement of the device without need for surgery. Seven-teen patients had TEE at six months: the shunt disappeared for 95% from the patients, no thrombus was found. No recurrent thromboembolic event appeared for the 18 patients (median follow-up 19.2 months).

Conclusion: The installation of a technique of percutaneous closing of the PFO+ASA is safe and effective.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adult
  • Aged
  • Atrial Septum*
  • Feasibility Studies
  • Female
  • Foramen Ovale, Patent / complications
  • Foramen Ovale, Patent / therapy*
  • France
  • Heart Aneurysm / complications
  • Heart Aneurysm / therapy*
  • Hospitals, General
  • Humans
  • Male
  • Middle Aged
  • Prostheses and Implants*